STRYKER CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 333.2 USD | -0.22% |
|
+0.64% | +11.09% |
| May. 16 | Stryker Insider Sold Shares Worth $3,276,516, According to a Recent SEC Filing | MT |
| May. 16 | Everlasting momentum |  |
Presenter SpeechAndrew Ranieri (Analysts)Thank you, everyone, for joining us today at the Morg...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows:
- surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment;
- orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants.
At the end of 2022, the group had 48 production sites worldwide.
Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Calendar
2024-07-22
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
334
USD
Average target price
372.4
USD
Spread / Average Target
+11.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.09% | 127B | |
| -5.10% | 11.32B | |
| +4.02% | 9.04B | |
| +37.48% | 5.56B | |
| -24.19% | 4.72B | |
| +8.53% | 3.45B | |
| -6.96% | 2.86B | |
| -5.85% | 2.07B | |
| -11.84% | 2.04B | |
| -23.36% | 1.77B |
- Stock Market
- Equities
- SYK Stock
- News Stryker Corporation
- Transcript : Stryker Corporation Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-13-2021 10
